| 3001 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
52 |
| 3002 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
66 |
| 3003 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
39 |
| 3004 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
53 |
| 3005 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
65 |
| 3006 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
58 |
| 3007 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
66 |
| 3008 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
71 |
| 3009 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
67 |
| 3010 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
67 |
| 3011 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
40 |
| 3012 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
54 |
| 3013 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
57 |
| 3014 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
70 |
| 3015 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
40 |
| 3016 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
71 |
| 3017 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
28 |
| 3018 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
88 |
| 3019 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
68 |
| 3020 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
71 |
| 3021 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
61 |
| 3022 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
62 |
| 3023 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
54 |
| 3024 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
71 |
| 3025 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
48 |
| 3026 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
1 |
| 3027 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
67 |
| 3028 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
66 |
| 3029 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
56 |
| 3030 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
40 |
| 3031 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
36 |
| 3032 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
37 |
| 3033 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
26 |
| 3034 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
20 |
| 3035 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
74 |
| 3036 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
55 |
| 3037 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
56 |
| 3038 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
48 |
| 3039 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
13 |
| 3040 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
65 |
| 3041 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
48 |
| 3042 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
67 |
| 3043 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
52 |
| 3044 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
50 |
| 3045 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
61 |
| 3046 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
35 |
| 3047 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
61 |
| 3048 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
47 |
| 3049 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
34 |
| 3050 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
62 |
| 3051 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
60 |
| 3052 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
62 |
| 3053 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
64 |
| 3054 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
29 |
| 3055 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
63 |
| 3056 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
1 |
| 3057 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
39 |
| 3058 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
43 |
| 3059 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
63 |
| 3060 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
21 |
| 3061 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
58 |
| 3062 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
45 |
| 3063 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
63 |
| 3064 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
54 |
| 3065 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
48 |
| 3066 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
61 |
| 3067 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
27 |
| 3068 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
61 |
| 3069 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
66 |
| 3070 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia – Relapse
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
47 |
| 3071 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia; Myelodysplastic Syndrome
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
55 |
| 3072 |
Apheresis |
Allogeneic
|
Acute Promyelocytic Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
49 |
| 3073 |
Apheresis |
Allogeneic
|
Acute Promyelocytic Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
40 |
| 3074 |
Apheresis |
Allogeneic
|
Alk-Positive Anaplastic T-Cell Lymphoma
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
15 |
| 3075 |
Apheresis |
Autologous
|
Anaplastic Large Cell Lymphoma
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
22 |
| 3076 |
Apheresis |
Allogeneic
|
Aplastic Anemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
22 |
| 3077 |
Apheresis |
Allogeneic
|
Aplastic Anemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
16 |
| 3078 |
Apheresis |
Allogeneic
|
Aplastic Anemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
17 |
| 3079 |
Apheresis |
Allogeneic
|
Aplastic Anemia
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
67 |
| 3080 |
Apheresis |
Allogeneic
|
Atypical Chronic Myeloid Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
62 |
| 3081 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
46 |
| 3082 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
18 |
| 3083 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
54 |
| 3084 |
Apheresis |
Allogeneic
|
Beta Thalassemia Major
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
11 |
| 3085 |
Apheresis |
Allogeneic
|
C-All Rez (Acute Lymphoblastic Leukemia)
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
66 |
| 3086 |
Apheresis |
Allogeneic
|
C-All Rez (Acute Lymphoblastic Leukemia)
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
5 |
| 3087 |
Apheresis |
Allogeneic
|
Chronic Granulomatous Disease
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
3 |
| 3088 |
Apheresis |
Allogeneic
|
Chronic Granulomatous Disease
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
3 |
| 3089 |
Apheresis |
Allogeneic
|
Chronic Granulomatous Disease
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
5 |
| 3090 |
Apheresis |
Allogeneic
|
Chronic Lymphocytic Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
63 |
| 3091 |
Apheresis |
Allogeneic
|
Chronic Lymphocytic Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
59 |
| 3092 |
Apheresis |
Allogeneic
|
Chronic Lymphocytic Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Germany
|
58 |
| 3093 |
Apheresis |
Allogeneic
|
Chronic Lymphocytic Leukemia Richter Transformation 7/22
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
44 |
| 3094 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
64 |
| 3095 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
67 |
| 3096 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
63 |
| 3097 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
59 |
| 3098 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
64 |
| 3099 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
60 |
| 3100 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2022
|
Standard Therapy
|
Poland
|
70 |